Allergan (AGN) Receives Positive Recommendation from EMA CHMP for OZURDEX Marketing Authorization
Tweet Send to a Friend
Allergan (NYSE: AGN) that the European Union’s Committee for Medicinal Products for Human Use (CHMP) has recommended extending the Marketing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
